期刊文献+

地特胰岛素与门冬胰岛素强化治疗2型糖尿病疗效观察

Effect of Insulin Detemir Combined Aspart in Intensive Insulin Therapy of Type 2Diabetes
下载PDF
导出
摘要 目的观察地特胰岛素联合门冬胰岛素强化治疗2型糖尿病患者的疗效。方法将118例口服降糖药物欠佳的2型糖尿病患者随机分为地特胰岛素联合门冬胰岛素组(N-D组),诺和灵R联合诺和灵N组(N-N组),连续治疗2周,分别于治疗前后测空腹血糖(FPG)、餐后2h血糖(2hPG)和空腹胰岛素(FINS),并分别计算HOMA-IR和HOMA-β,记录血糖达标时间、达标日胰岛素类似物用量和低血糖发生频率。结果 N-G组与N-N组FBG、2hPG、Homa-β和Homa-IR比较均无显著性差异,P>0.05;两组强化治疗前后组内比较FPG、2hPG、Homa-β和Homa-IR比较均为P<0.01;而N-G组的糖达标时间、胰岛素用量和低血糖发生率均较N-N组低,P<0.01。结论地特胰岛素联合诺和锐强化治疗可以明显改善胰岛B细胞功能,降低胰岛素抵抗,使多数口服降糖药物控制血糖欠佳的2型糖尿病患者血糖更加快速、安全达标。 OBEJECTIVE To observe the effect of Isnulin Detemir combined with Aspart insulin in intensive therapy of patients with type 2diabetes patients.METHODS 118 poor oral hypoglycemic drugs in patients with type 2 diabetes were assigned to group N-G or group N-N,Continuously for 2 weeks,and record the patients before and after treatment of blood glucose,2-hour postprandial blood glucose,Fasting insulin,Homa-IR,Homa-β,the number of days to compare standards,Standards on the Insulin dosages,the frequency of hypoglycemia.RESULTS Compared with two groups after intensive insulin therapy there were no significant difference in FBG,2 h PG,Homa-β,Homa-IR,P0.05.Each group before and after intensive treatment there were significant difference in FPG、2 h PG、Homa-β、Homa-IR,P0.01.The standard time of sugar N-D group faster than N-N group,P0.01,the Insulin dosage and the frequency of hypoglycemia N-G group were less than N-N group,P0.01.CONCLUSION Insulin Detemir combined aspart in intensive insulin therapy of type 2 diabetes can significantly improve the islet B cell function,reduce insulin resistance,So that the majority of oral hypoglycemic drugs control in type 2 diabetic patients with poor blood sugar more quickly and safety standards.
出处 《中国初级卫生保健》 2011年第4期101-102,共2页 Chinese Primary Health Care
关键词 地特胰岛素 门冬胰岛素 强化治疗 2型糖尿病 insulin detemir aspart insulin intensive therapy type 2 diabetes mellitus
  • 相关文献

参考文献4

二级参考文献16

  • 1Weyer. Dificiency in AIR predict IGT and Type 2 diabetes. Diabetes Care, 2001,24 : 89-94.
  • 2Haffner SM, Miettinen H, Gaskill SP, et al. Decreased insulin secretion and increased insulin resistance are independently related to the 7-year risk of NIDDM in Mexican-Americans. Diabetes, 1995,44: 1386-1391.
  • 3Bruce DG, Chisholm DJ, Leonare H, et al. Physiological importance of deficiency in early prandial insulin secretion in non-in-sulin-dependent diabetes. Diabetes, 1988,37: 736-743.
  • 4Bruttomesso D, Pianta A, Mari A, et al. Restoration of early rise in plasma insulin levels improves the glucose tolerance of type 2 diabetic patients. Diabetes, 1999,48: 99-105.
  • 5Ilkova H, glaser B, Tunckale A, et al. Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients by transient intensive insulin treatment. Diabetes Care, 1997,20:1353-1356.
  • 6Walton C, Godsland IF, Proudler AJ, et al. Effect of body mass index and fat distribution on insulin sensitivity, secretion, and clearance in nonobese healthy men. J Clin Endocrinol Metab,1992,75: 170-175.
  • 7Purrello F, Rabuazza AM. Metabolic factors that affect betacell function and survival. Diabet Nutr Metab, 2000, 13: 84-91.
  • 8Sivitz WI. Lipotoxieity and glueotoxieity in type 2 diabetes. Effects on development and progression. Postgrad Med, 2001,109: 55-59,63-64.
  • 9Lenhard M J, Reeves GD. Continous subcutaneous insulin infusion: a comprehensive review of insulin pump therapy. Arch Intern Med,2001,161: 2293-2300.
  • 10Dupuy O, Mayaudon H, Palou M, et al. Optimized transient insulin infusion in uneontrolled type 2 Diabetes : Evaluation of a pragmatie attitude. Diabet Med, 2000,26 : 371-375.

共引文献1316

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部